Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 08/09/2011
PIL Celance 50, 250, 1000 microgram tablets. - Product discontinued

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/09/2011 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 27/10/2010 and displayed until 08/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 05/03/2010 and displayed until 27/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/08/2009 and displayed until 05/03/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 26/06/2009 and displayed until 25/08/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 02/03/2009 and displayed until 26/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 27/10/2008 and displayed until 02/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 02/05/2008 and displayed until 27/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 11/01/2008 and displayed until 02/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to Marketing Authorisation Holder
  • Change to manufacturer contact details
  • Change to date of revision
Updated on 05/02/2007 and displayed until 11/01/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
  • Change to date of revision
Updated on 07/08/2006 and displayed until 05/02/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/02/2005 and displayed until 07/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 24/09/2004 and displayed until 04/02/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 13/01/2003 and displayed until 24/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 26/04/2001 and displayed until 13/01/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 03/08/2000 and displayed until 26/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  pergolide mesilate